FIORY, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.109
EU - Europa 546
AS - Asia 518
SA - Sud America 16
AF - Africa 13
Totale 2.202
Nazione #
US - Stati Uniti d'America 1.064
SG - Singapore 243
IT - Italia 180
CN - Cina 153
HK - Hong Kong 108
NL - Olanda 58
IE - Irlanda 57
FI - Finlandia 52
RU - Federazione Russa 49
CA - Canada 45
DE - Germania 42
SE - Svezia 38
GB - Regno Unito 26
UA - Ucraina 19
BR - Brasile 13
CI - Costa d'Avorio 12
PL - Polonia 6
AT - Austria 5
IN - India 5
FR - Francia 4
LT - Lituania 4
BE - Belgio 3
JP - Giappone 3
TR - Turchia 3
UZ - Uzbekistan 2
AR - Argentina 1
CO - Colombia 1
ES - Italia 1
KR - Corea 1
PT - Portogallo 1
SI - Slovenia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 2.202
Città #
Chandler 213
Singapore 152
Hong Kong 108
Santa Clara 103
Ashburn 97
Napoli 67
Amsterdam 56
Millbury 52
Princeton 48
Nanjing 38
Ottawa 38
Boston 33
Jacksonville 29
Beijing 28
Des Moines 21
Wilmington 13
Washington 11
Naples 9
Shenyang 9
Falkenstein 8
Hebei 8
Helsinki 8
Jiaxing 8
Tianjin 8
Lawrence 7
Norwalk 7
Frankfurt am Main 6
Nanchang 6
Toronto 6
Boardman 5
Kunming 5
Seattle 5
Cava De' Tirreni 4
Falls Church 4
Hangzhou 4
Jinan 4
London 4
Pune 4
Brussels 3
Caserta 3
Dallas 3
Hanover 3
Los Angeles 3
Paris 3
The Dalles 3
Casoria 2
Centrale 2
Chengdu 2
Citta Sant'angelo 2
Dalmine 2
Guangzhou 2
Houston 2
Kronberg 2
Maddaloni 2
Milan 2
Ningbo 2
Nuremberg 2
Osaka 2
Scafati 2
Skövde 2
São Paulo 2
Tashkent 2
Vienna 2
Zhengzhou 2
Altavilla Silentina 1
Ann Arbor 1
Arteaga 1
Atella 1
Augusta 1
Aversa 1
Bacoli 1
Bizerte 1
Bogotá 1
Caracas 1
Carnaíba 1
Carrara 1
Changchun 1
Changsha 1
Chernihiv 1
Clifton 1
Condado 1
Council Bluffs 1
Curitiba 1
Dublin 1
Fairfield 1
Fossombrone 1
Giugliano in Campania 1
Itambé 1
Kagoya 1
Lappeenranta 1
Mainz 1
Melito Di Napoli 1
Munich 1
New York 1
Nocera Inferiore 1
Parauapebas 1
Pelotas 1
Pesaro 1
Pompei 1
Porto Alegre 1
Totale 1.331
Nome #
Circulating miRNAs as intercellular messengers, potential biomarkers and therapeutic targets for Type 2 diabetes 77
Prep1 Deficiency Affects Olfactory Perception and Feeding Behavior by Impairing BDNF-TrkB Mediated Neurotrophic Signaling 76
Glucose regulates diacylglycerol intracellular levels and protein kinase C activity by modulating diacylglycerol-kinase subcellular localization. 71
Potential Mechanisms of Bisphenol A (BPA) Contributing to Human Disease 71
Phorbol esters induce intracellular accumulation of the anti-apoptotic protein PED/PEA-15 by preventing ubiquitinylation and proteasomal degradation. 63
Altered PTPRD DNA methylation associates with restricted adipogenesis in healthy first-degree relatives of Type 2 diabetes subjects 62
Adenoviral gene transfer of PLD1-D4 enhances insulin sensitivity in mice by disrupting phospholipase D1 interaction with PED/PEA-15. 60
Epigenetic modifications of the Zfp/ZNF423 gene control murine adipogenic commitment and are dysregulated in human hypertrophic obesity 55
Insulin receptor substrate-2 phosphorylation is necessary for protein kinase czeta activation by insulin in l6hir cells. 54
Parkinson-like phenotype in insulin-resistant PED/PEA-15 transgenic mice 54
Specific CpG hyper-methylation leads to Ankrd26 gene down-regulation in white adipose tissue of a mouse model of diet-induced obesity 54
Citrus aurantium L. dry extracts promote C/ebpβ expression and improve adipocyte differentiation in 3T3-L1 cells. 54
Molecular cloning and characterization of the human PED/PEA-15 gene promoter reveal antagonistic regulation by hepatocyte nuclear factor 4alpha and chicken ovalbumin upstream promoter transcription factor II. 52
miR-214-dependent increase of PHLPP2 levels mediates the impairment of insulin-stimulated akt activation in mouse aortic endothelial cells exposed to methylglyoxal 52
A peptide antagonist of Prep1-p160 interaction improves ceramide-induced insulin resistance in skeletal muscle cells 51
Pathologic endoplasmic reticulum stress induced by glucotoxic insults inhibits adipocyte differentiation and induces an inflammatory phenotype 50
The Relevance of Insulin Action in the Dopaminergic System 50
Alterations of PED/PEA-15 gene at the interface of diabetes and Parkinson disease 49
The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells 48
Insulin affects tyrosine hydroxylase expression in neuronal PC12 cells through Hif-1alpha activation 47
Methylglyoxal impairs insulin signalling and endothelial function both in vitro and in vivo 47
In L6 cells, glucose induces cytosolic translocation of PKC alpha, trans-activates the insulin receptor kinase and regulates its own uptake 46
Role of the HIF-1α/Nur77 axis in the regulation of the tyrosine hydroxylase expression by insulin in PC12 cells 46
GRP78 mediates cell growth and invasiveness in endometrial cancer. 45
In skeletal muscle, advanced glycation end products inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. 44
Insulin-activated protein kinase Cbeta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells 42
Unravelling the methylglyoxal effect on the angiogenic process 42
Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism. 41
Selective disruption of insulin-like growth factor-1 (IGF-1) signaling via phosphoinositide-dependent kinase-1 prevents the protective effect of IGF-1 on human cancer cell death. 41
Insulin regulates tyrosine hydroxylase expression in neuronal pc12 cells 41
Diabetes and cognitive impairment: A role for glucotoxicity and dopaminergic dysfunction 41
Thrombin-activated platelets induce proliferation of human skin fibroblasts by stimulating autocrine production of insulin-like growth factor-1 40
Insulin receptor internalization and intracellular sorting are regulated by protein kinase C-zeta and protein kinase b/Akt. 40
Insulin induces the interaction of IRS-1 with PKC-alpha and 14-3-3-epsilon 39
Methylglyoxal impairs endothelial insulin sensitivity both in vitro and in vivo. 37
The role of miR-190a in methylglyoxal-induced insulin resistance in endothelial cells 37
Dicarbonyl Stress at the Crossroads of Healthy and Unhealthy Aging 37
In L6 skeletal muscle tells advanced glycation end products inhibit insulin action by activating src and inducing the formation of a multi-molecular complex 35
Hyperglycaemia enhances the expression of the diabetogene ped/pea-15 through chromatin remodelling 35
The Role of miRNAs in Methylglyoxal-induced Endothelial Insulin Resistance 35
PED/PEA-15 inhibits hydrogen peroxide-induced apoptosis in Ins-1E pancreatic beta-cells via PLD-1 34
Targetting PED/PEA-15 for diabetes treatment 34
The plant hormone abscisic acid increases in human plasma after hyperglycemia and stimulates glucose consumption by adipocytes and myoblasts. 33
Tyrosine phosphorylation of phosphoinositide-dependent kinase 1 by the insulin receptor is necessary for insulin metabolic signaling 30
Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15 29
Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase 29
Protein kinase C-alpha regulates insulin action and degradation by interacting with insulin receptor substrate-1 and 14-3-3 epsilon. 29
PDK1 interaction with insulin receptor and tyrosine phosphorylation are required for insulin metabolic action. 28
Metformin dysregulates the unfolded protein response and the WNT/β-catenin pathway in endometrial cancer cells through an AMPK-independent mechanism 28
Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer 27
The serine protease OMI/HtrA2 interacts with PED (phosphoprotein enriched in diabetes) and controls its anti-apoptotic function 27
Insulin stimulates phosphoinositides-dependent kinase (PDK)-1 binding to insulin-receptor C-terminus followed by tyrosine-phosphorylation and activation. 27
Protein kinase C-zeta and protein kinase B regulate distinct steps of insulin endocytosis and intracellular sorting 25
Thiazolidinediones control the expression of Ped/Pea-15 (phosphoprotein enriched in diabetes) both in vitro and in vivo 25
Overexpression of the ped/pea-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action 24
Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E. 22
Totale 2.412
Categoria #
all - tutte 11.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.297


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202079 0 0 0 0 0 0 0 0 9 9 32 29
2020/2021163 11 4 30 6 6 27 45 4 18 5 6 1
2021/2022357 5 1 0 2 11 10 3 8 63 16 105 133
2022/2023449 58 54 26 17 55 63 0 30 64 57 17 8
2023/2024283 10 42 19 40 27 57 2 22 2 4 41 17
2024/2025645 72 75 3 13 100 97 145 101 39 0 0 0
Totale 2.412